We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




3D Model Could Enable Earlier Detection of Esophageal Cancer

By HospiMedica staff writers
Posted on 19 Nov 2007
A new model of esophageal cancer holds promise as an experimental platform to investigate the etiology and possible treatment of this devastating disease. More...


There are two main types of esophageal cancer: squamous cell carcinoma and adenocarcinoma. Esophageal squamous cell carcinoma (ESCC) is the third most common cancer of the digestive tract and the seventh leading cause of cancer-related deaths worldwide. It is a highly malignant cancer and generally carries a poor prognosis, owing to its predominantly late detection.

A team of scientists from the University of Pennsylvania (Philadelphia, PA, USA), led by Dr. Anil Rustgi, developed the new model of ESCC. "This model allows us to dissect the specific genetic alterations that are important in the initiation and progression of esophageal squamous cell cancer, which holds promise for squamous cell cancers arising in other sites, such as the skin, lung, head, and neck,” explained Dr. Rustgi.

Dr. Rustgi and colleagues developed a tissue-engineered, organotypic three-dimensional (3D) culture system of esophageal squamous cell cancer. They found that ESCC results from a combination of genetic mutations (namely, epidermal growth factor receptor [EGFR] overexpression, hTERT activation, and p53 mutation), as well as changes in the tumor microenvironment.

Dr. Rustgi emphasized, "we have found that altering the stromal fibroblasts can influence the extent of tumor cell migration and invasion. Thus, previously underappreciated, it is the interplay of tumor cells and fibroblasts that has great meaning on how cancer arises and progresses.”

The model was described in the November 1, 2007, issue of the journal Genes and Development.


Related Links:
University of Pennsylvania

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Aliya EX Generator for surgical ablation of soft tissue (Photo courtesy of Galvanize Therapeutics)

Next-Generation PEF System Delivers Larger Ablation Zones for Soft-Tissue Procedures

Interventional teams often need soft-tissue ablation options that can be performed percutaneously or endoscopically while minimizing collateral injury and preserving procedural workflow.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.